Winton Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,259
Closed -$276K 1244
2018
Q1
$276K Buy
+9,259
New +$299K 0.01% 1007

Other funds holding LJPC

Winton Group's LJPC Position: Q2 2018 in Review

Winton Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 9,259 shares — an estimated $276K sold.

Winton Group first reported a position in LJPC in Q1 2018 and held it in 1 quarter. The position peaked at $276K in Q1 2018. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

  • Winton Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
  • Winton Group sold 9,259 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $276K.
  • Winton Group first reported a position in La Jolla Pharmaceutical Company in Q1 2018 and held it in 1 quarter.
  • Winton Group's La Jolla Pharmaceutical Company position peaked at $276K in Q1 2018.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on Winton Group's 13F filing for Q2 2018, filed 20 Aug 2018.